Video
Industry, Events
Microbiomepost conducted an exclusive interview with Martina Piacente, from Ebris - European Biomedical Research Institute of Salerno, about the role of gut microbiome in Autism Spectrum Disorder.
Events, Industry
Microbiomepost conducted an exclusive interview with Antonio Paoli, full professor of Sport and Exercise Sciences at University of Padua, in Italy, about how exercise interferes with gut microbiome.
Industry, Events
Microbiomepost conducted an exclusive interview with Nuria Vieco, Adisseo France S.A.S, European Laboratory of Innovation Science and Expertise ELISE, about the effect of Bacillus subtilis DSM29784 secreted metabolites on poultry…
Industry, Events
Microbiomepost conducted an exclusive interview with Jiri Snaidr, Founder and CEO at Vermicon AG, about the possibility to combine Fluorescence In Situ Hybridization (FISH) and Digital PCR (dPCR) for advanced…
Industry, Events
Microbiomepost conducted an exclusive interview with Eric Daliri, from Vilnius University, about the possibility of prevent diabetes modulating gut microbiome.
Industry, Events
Microbiomepost conducted an exclusive interview with Nina Vinot, Bioprox Healthcare, about the new frontiers of the microbiome revolution: the role of soil microbiome in the agriculture space.
Gastroenterology, Events
Satish Chandran, President and Chief Executive Officer at Prodigy Biotech, Inc., details the company's program aimed at treating alcoholic liver disease, spotlighting Enterococcus faecalis as the primary antagonist.
Video, Industry
MicrobiomePost carried out a research analysis in collaboration with Analytics Arts to find out more about the motivations and frequency of probiotic consumption and the level of consumer information.
Video, Events
Aran Singanayagam, research group leader at Imperial College London (UK), examined how disturbances in the airway microbiome are instrumental in the development of chronic lung diseases.
Video, Dermatology
An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…